Showing results (631-640 of 736) with videos related to

Sort By:
Pageof 74
Blood|July 5, 2024
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylationKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
American Journal of Hematology|April 27, 2013
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphomaThomas E Witzig, Gregory A Wiseman, Matthew J Maurer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 1, 2018
Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative DisordersLarissa Higgins, Samih H Nasr, Samar M Said, et al.
Leukemia|March 7, 2020
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCLKeenan T Hartert, Kerstin Wenzl, Jordan E Krull, et al.
Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphomaCarrie A Thompson, Herve Ghesquieres, Matthew J Maurer, et al.
Blood|June 15, 2016
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphomaRebecca L Boddicker, Gina L Razidlo, Surendra Dasari, et al.
British Journal of Haematology|August 2, 2021
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemiaSaurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib StudyAlexander M Lesokhin, Stephen M Ansell, Philippe Armand, et al.
Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.
Pageof 74